|
|
Please join us to attend the presentation of our next BTSG speaker:
Time: Monday December 14, 2009, 4pm.
Place: Room 165 of the Davis H&L Research Institute.
.
Speaker: Dr. Kamalakannan Palanichamy, PhD, Assistant Professor of Radiation Medicine (OSU).
Title: “Role of Brain Tumor Stem Cells in Mediating Treatment Resistance and Developing Models to Investigate Stem Cell Biology”.
Cancer stem cells have surfaced in the past few years as the major, and perhaps the most critical, target for successful interventions against malignant brain tumors. Since his recent arrival to Ohio State, “PK” Palanichamy has focused on understanding the properties of brain tumor stem cells that make them resistant to conventional therapies and on how these cells can tell us more about the biology of normal stem cells in the brain.
Notice on links: Our article links are now pointing to the PubMed abstracts only. You can get a direct link to the papers from there or, if you are at OSU, you can also try the Electronic Journal Center of OHIO LINK.
Don’t miss this seminar sponsored by the College of Public Health:
Allergy and inflammation-related pathways affect glioblastoma risk
.
Judith Schwartzbaum, PhD, Associate Professor of Epidemiology (CPH-OSU).
Wednesday November 18, 2009, 12:30pm.
M100, Starling-Loving Hall, 320 West 10th Ave.
For additional info, email to CPH seminar series: cphevents@cph.osu.edu
Please join us to attend the presentation of our next BTSG speaker:
Time: Monday November 9, 2009, 4pm.
Place: Room 165 of the Davis H&L Research Institute.
.
Speaker: Dr. Rolf F. Barth, MD, Professor of Pathology (OSU).
Title: “Chemoradiotherapeutic Approaches for the Treatment of Brain Tumors”.
Radiation Therapy continues to be the predominant therapeutic approach, after surgery, against malignant brain tumors. For over 25 years Dr. Barth has studied different modalities to improve the clinical treatment of of these tumors using combinations of chemo- and radiotherapeutic agents and he will present the latest advances in glioma chemoradiotherapy at our next meeting:
Notice on links: Our article links are now pointing to the PubMed abstracts only. You can get a direct link to the papers from there or, if you are at OSU, you can also try the Electronic Journal Center of OHIO LINK.
We skipped a monthly meeting but are back!
Please join us to attend the presentation of our next BTSG speaker:
Time: Monday October 12, 2009, 4pm.
Place: Room 165 of the Davis H&L Research Institute.
.
Speaker: Dr. James Van Brocklyn, PhD, Assistant Professor at the Department of Pathology (OSU).
Title: “Sphingolipid-mediated signaling in glioblastoma”.
Sphingolipids are potent signaling [...]
Please join us to attend the presentation of our next BTSG speaker:
Time: Monday August 10, 2009, 4pm.
Place: Room 165 of the Davis H&L Research Institute.
Our speaker will be Dr. Sean Lawler, PhD, Assistant Professor at the Department of Neurological Surgery (OSU).
The title of his presentation is “MicroRNAs in glioblastoma: mechanistic insights and clinical potential”. [...]
For those of you who could not attend last week’s BTSG meeting, Tim Lautenschlaeger has kindly sent us some slides from his presentation. He talked about the high expression of galectins in malignant gliomas and the potentially new pathways activated by these curious proteins that act both inside and outside the cells.
For more details, please [...]
Please join us for an OSUCCC Special Viral Oncology Lecture on Wednesday, July 22, 2009 in room 115 of the Biomedical Research Tower:
PI3K Signaling in Normal and Tumorigenic Growth in Brain
Speaker:
Suzanne Baker, Ph.D.
Affiliated Associate Professor
Department of Pathology
University of Tennessee, Memphis
Associate Member
Department of Developmental Neurobiology
St. Jude Children’s Research [...]
“An attempt is made in this paper to consider ‘metastasis’ in malignant disease, and to show that the distribution of the secondary growths is not a matter of chance”
[beginning of Stephen Paget's seminal paper that proposed the hypothesis of compatible "seed and soil" for cancer dissemination. The Lancet, 1889 (1):571]
The Department of Neurosurgery has [...]
Please join us to attend the presentation of our next BTSG speaker:
Time: Monday July 13, 2009, 4pm.
Place: Room 165 of the Davis H&L Research Institute.
Our speaker will be Dr. Tim Lautenschlaeger, MD, Assistant Professor at the Department of Radiation Medicine (OSU).
The title of his presentation is “Ras, Pi3K and MAPK: How galectins mediate radioresistance in glioma”. [...]
The International Neuro-Oncology Update conference will have its 8th Annual venue in Columbus, Ohio this year and will be hosted by Dr. Nino Chiocca, Chair of the Department of Neurological Surgery at OSU (click on the flyer for details).
This conference brings together researchers and clinical practitioners to discuss research advances and innovations in treatments for [...]
|
|
